Narrow Results

SARS Brings Out Taiwan’s Sovereignty Issue.

Asean Countries to Fight SARS Together.

Thermal Scanner Becomes Hot Anti-SARS Device.

Businesses Quick to Cash In on SARS Crisis.

SARS Strikes Hard in Taiwan.

Taiwan’s Anti-SARS Compromised by Uncooperative Citizens.

Cover Up in Ho Ping.

Taiwan Braces Itself for Economic Ramifications.

Chinese Medicine to Combat SARS.

Control Measures for Severe Acute Respiratory Syndrome (SARS) in Taiwan.

Beijing Formulates Contingency Plan to Guard Against SARS Resurgence.

ASMR Reports a Five-fold Economic Return for Health R&D Expenditure.

New Pharmaceuticals Partnerships Program in Australia.

Japanese Gearing Up for Possible SARS Outbreak.

New Mad Cow Case in Japan Sparks Fear of New Viral Strain.

Pakistan's Initiatives in Biotechnology.

Biotechnology Looking Up Again in Taiwan and Asia Pacific.

New Radiotherapy Center in Australia.

Breakthrough in Cardiac Disease Treatment.

New Prostheses Available in Taiwan.

Plans for New Herbal Medicine Research Facility.

Health Concerns over Herbal Beverages' Alcohol Contents.

Dapumei Herbal Biotechnology Park in Taiwan.

Fat Reducing Fruit.

Multivalent Anti-Bacterial Vaccines Available for Fish.

Free Trade Zones in Taiwan by 2008.

Moth Released to Control Mimosa Spread.

New Agricultural Treasury Established in Taiwan.

Sumitomo Chemical and Bayer CropScience Develop New Rice Fungicide.

A*STAR Partners with Top UK University.

New York Academy of Sciences, the Chinese Academy of Sciences and the Shanghai Institutes of Biomedical Sciences Host a Groundbreaking Conference.

Taiwan and Israel Collaborate on Nanotechnology and Biomedical Science.

GAU Signs MoU with IAF to Popularize Ayurveda Globally.

WHO Hails Multi-million Dollar Funding to Fight TB Pandemic.

Rockeby Completes Further Distribution of Avian Flu Diagnostic Deals in Europe, Asia and the Middle East.

CyGenics in International Cancer Therapy Collaboration.

Western Australia Leads to Crack Diabetes Code.

China Intends to Push for GM Crop Studies.

Taiwan Government to Fund Biotech Industry Development.

Australian Scientists Collaborate with US Researchers on Lupus Research.

Japan to Increase its Expenditure on Sciences.

Bird Flu Moves Closer to Italy, Britain, France, Germany and Nigeria.

Dr Reddy's Acquires Betapharm.

Singapore EDB Aims to Attract $10 Billion Research Investments.

Singapore at the Forefront of Lipid Research.

Bristol-Myers Squibb Licenses AIDS Drug Free to Third World Drug Manufacturers.

The Biotechnology Incubation Center of Academia Sinica: A Gateway to Innovative Taiwan.

Cancer Targeting Nanomedicine: An Opportunity for Drug Development in Asia with Emphasis on Taiwan.

Recombinant Lipoproteins for the Development of Novel Subunit Vaccines.

Discovery of Therapeutic Human Monoclonal Antibodies through B-cell Immortalization Technology.

Toxicity of Engineered Nanomaterials.

2013 – A Year of Access, Convergence and Technology.

Cancer Targeting Nanomedicine: An Opportunity for Drug Development in Asia with Emphasis on Taiwan.

ASEAN Economic Community 2015: Opportunities for Trade and Investment in Thailand's Biotechnology Sector.

Quality Issues in Pharmaceuticals: An Overview into Root Cause Investigations.

Hospitals' Community Benefits: A Measure of Social Responsibility in Health Care.

Journey to the East: The growing Role of Asian Headquarters for Multinational Life Sciences Companies.

Therapy for Hippocampus Injury: Can Neural Stem Cells Help?

Nanject: Drug Delivery Cancer Cells Detection.

Science Communication: Singapore Science Centre Style.

NEWS – Lilly and Innovent Biologics enter strategic alliance; one of the largest biotech drug development collaborations in China.

NEWS – ZAI Lab enrolls first patient in Phase 1 study of ZL-2102.

NEWS – LamdaGen Corporation launches Taiwan diagnostic subsidiary.

NEWS – 3M makes a greater commitment in China's West Region; Plans for a new customer technical center.

NEWS – NCKU launches campus food ingredients registration platform.

NEWS – Lab-free immune therapy developed.

NEWS – Hainan Province, Hengda Health and Korean Yuanchen enter strategic cooperation agreement.

NEWS – Bristol-Myers Squibb and ZAI Lab enter licensing agreement to develop, manufacture and commercialize brivanib in China.

NEWS – Concord Medical acquires Fortis Surgical Hospital in Singapore.

NEWS – Merck Animal Health and China Animal Husbandry Industry Co., Ltd establish partnership.

NEWS – Helsinn Group signs exclusive agreement with Mundipharma for distribution and license of anamorelin in China, Hong Kong and Macau.

NEWS – C-FDA approves IND for D-Pharm's anti-epileptic drug, DP-VPA in China.

NEWS – Waters' UPLC I-Class/Xevo TQ-S System approved for in vitro diagnostic use in China.

NEWS – Vitruvias Therapeutics and Sunny Pharmtech form partnership to co-develop several high value generic drugs.

NEWS – Professor Xie Xiaoliang first Chinese Albany Award winner.

RESEARCH INSTITUTES – A look at Duke Kunshan University Global Health Research Center.

RESEARCH INSTITUTES – The NYU-ECNU Institute of Brain and Cognitive Science.

A Glimpse into Healthcare Policies: How Cancer Control and Prevention Programmes Have Evolved Across Asia.

Understanding Healthcare Policies in the Philippines: Cancer Care.

Healthcare Systems and Health Policies in Thailand: Cancer Care.

Cancer Care and Control in Taiwan: An Interview with Dr. Shu-Ti Chiou.

An Interview with Professor Myint Han: Healthcare in Myanmar.

SINGAPORE – Singapore eHealth Innovations Summit Announces the First EMRAM Stage 7 Hospital in Singapore and Emphasized Technology as Transformative Agent in Specialty Functions.

TAIWAN – Health2Sync Strategically Partners with Taiwan's Ministry of Health and Welfare in Asia's First Government Supported Online Diabetes Care Program.

UNITED STATES – Scientists Identify Protein Involved in Restoring Effectiveness of Common Treatment for Breast Cancer.

UNITED STATES – Scientists Reveal How Signals from Pathogenic Bacteria Reach Danger Sensors of Cells.

UNITED STATES – Scientists Find New Path in Brain to Ease Depression.

UNITED STATES – Tips for Living a Heart Healthy Lifestyle.

CANADA – Review Suggests Eating Oats Can Lower Cholesterol as Measured by a Variety of Markers.

SOUTH KOREA – CSA Group Opens Highly Advanced Electro - Medical Laboratory in Seoul.

AUSTRALIA – Cynata’s Technology Significant Efficacy in Preclinical Asthma Study.

INDIA – Essilor Launches ‘Love to See Change’ Campaign to Educate People about Need to Preserve Visual Health.

This paper seeks to identify which factors are important for estimating portfolio's expected return and standard deviation in the Taiwan stock market. We have summarized from the existing empirical literature a total of 26 factors that may have explanatory power. The results of our evaluation show that except for the trading volume, the remaining 25 factors do not seem to help explain the average stock returns during the July 1985–June 1999 period. However, the power of the trading volume to account for the expected returns on the stock is affected by any changes in the sample or by the use of a different evaluation model. We suggest three potential explanations of why all 26 factors show no stable power to explain average returns on Taiwan stocks: high volatility, selection bias, and market differences. Moreover, we find that all of the 26 factors are important in capturing the systematic covariation in stock returns.

The experiences of Taiwan and Thailand following the 1997 crisis of the baht provide evidence of the importance of the quality of the financial infrastructure of a country in its ability to deal with unstable financial markets. The very high quality of the financial infrastructure in Taiwan (together with its peripheral role in the crisis itself) enabled its economy to escape relatively unscathed. In contrast, a lack of sophisticated financial institutions and nonfinancial firms both triggered the crisis in Thailand and required the Thai economy to experience its full force.